(Q38779572)

6 September 2017

0 references

Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis (English)

1 reference

6 September 2017

1 reference

1 reference

1 reference

4

Lars V Kessing

0 references

Maj Vinberg

series ordinal

5

object named as

Maj Vinberg

1 reference

6 September 2017

Michael Berk

3

0 references

Roger S McIntyre

series ordinal

10

object named as

Roger S McIntyre

1 reference

6 September 2017

8

Elisa Brietzke

1 reference

6 September 2017

9

Benjamin I Goldstein

1 reference

6 September 2017

1

Joshua D Rosenblat

1 reference

6 September 2017

6

Bernhard T Baune

1 reference

6 September 2017

7

Rodrigo B Mansur

1 reference

6 September 2017

Ron Kakar

2

1 reference

6 September 2017

publication date

18 March 2016

1 reference

6 September 2017

1 reference

6 September 2017

volume

18

1 reference

6 September 2017

issue

2

1 reference

6 September 2017

page(s)

89-101

1 reference

Prevalence, chronicity, burden and borders of bipolar disorder

6 September 2017

cites work

1 reference

Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.

21 January 2018

1 reference

Inflamed moods: a review of the interactions between inflammation and mood disorders

21 January 2018

1 reference

Are medical comorbid conditions of bipolar disorder due to immune dysfunction?

21 January 2018

1 reference

A biochemical basis for the actions of lithium on behaviour and on immunity: relapsing and remitting disorders of inflammation and immunity such as multiple sclerosis or recurrent herpes as manic-depression of the immune system

21 January 2018

1 reference

Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?

21 January 2018

1 reference

Cytokines in bipolar disorder: paving the way for neuroprogression.

21 January 2018

1 reference

Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis

21 January 2018

1 reference

The immunology of bipolar disorder

21 January 2018

1 reference

Chemokines in bipolar disorder: trait or state?

21 January 2018

1 reference

Cytokines in bipolar disorder: a systematic review and meta-analysis

21 January 2018

1 reference

Elevated levels of IL-6 and IL-18 in manic and hypomanic states in rapid cycling bipolar disorder patients

21 January 2018

1 reference

Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder

21 January 2018

1 reference

Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder

21 January 2018

1 reference

A meta-analysis of cytokines in major depression

21 January 2018

1 reference

So depression is an inflammatory disease, but where does the inflammation come from?

21 January 2018

1 reference

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials

21 January 2018

1 reference

Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis

21 January 2018

1 reference

A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression

21 January 2018

1 reference

Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness

21 January 2018

1 reference

Taking the fuel out of the fire: evidence for the use of anti-inflammatory agents in the treatment of bipolar disorders.

21 January 2018

1 reference

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

Meta-analysis: principles and procedures

21 January 2018

1 reference

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

21 January 2018

1 reference

Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder

21 January 2018

1 reference

Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.

21 January 2018

1 reference

Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study

21 January 2018

1 reference

Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder

21 January 2018

1 reference

Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study.

21 January 2018

1 reference

Aspirin for treatment of lithium-associated sexual dysfunction in men: randomized double-blind placebo-controlled study

21 January 2018

1 reference

N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial

21 January 2018

1 reference

Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial

21 January 2018

1 reference

Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder.

21 January 2018

1 reference

N-acetylcysteine for major depressive episodes in bipolar disorder

21 January 2018

1 reference

N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial.

21 January 2018

1 reference

A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania

21 January 2018

1 reference

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial

21 January 2018

1 reference

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers

21 January 2018

1 reference

Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.

21 January 2018

1 reference

Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trial

21 January 2018

1 reference

Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression

21 January 2018

1 reference

Omega-3 fatty acid treatment, with or without cytidine, fails to show therapeutic properties in bipolar disorder: a double-blind, randomized add-on clinical trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BDI.12373

1 reference

6 September 2017

1 reference